Armistice Capital, LLC 13D and 13G filings for Aquestive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:47 pm Sale |
2024-09-30 | 13G | Aquestive Therapeutics, Inc. AQST |
Armistice Capital, LLC | 2,750,000 2.930% |
-1,174,000 (-29.92%) |
Filing |
| 2024-02-14 3:24 pm Purchase |
2023-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
Armistice Capital, LLC | 3,924,000 5.880% |
3,924,000 (New Position) |
Filing |